Keywords

• Tesamorelin
• Egrifta
• CAS 218949-48-5

Quick Details

• ProName: GHRH Peptide Powder Tesamorelin For Fa...
• CasNo: 218949-48-5
• Molecular Formula: C221H366N72O67S
• Appearance: White Crytalline Powder
• Application: Muscle building peptides, human growth...
• DeliveryTime: Within 24 hours after receiving paymen...
• PackAge: designed disguised packing ways, 100% ...
• Port: Shenzhen
• ProductionCapacity: 100 Kilogram/Week
• Purity: 99%
• Storage: Store in a cool and dry place, keep dr...
• Transportation: HKEMS, DHL, TNT, UPS, FEDEX, EMS, Chin...
• LimitNum: 1 Gram

Superiority

1. We have experience in exporting steroids, as you know, EU places much emphasis on them, and you must find a experienced partner who will assure you;

2. Quality: Our company is a professional leading factory in China in pharmaceutical area, We had stable customers and exported to Germany, Spain, UK, USA, Australia, Middle East, and any other countries. We can provide good references about our company. As for the quality of the products, we 're sure they can satisfy you well enough;

3. Package: Professional packing with professional materials

4. Delivery: We have products in stock, and we will deliver them soon when your PO arrived.

Meanwhile we will give you the tracking number in order to make you know the exact location of the products. We will keep track of the product until they arrive you; We choose the best courier service for you, and with the delivery around 4-7 working days.

5. Service: Best Service with after-sales service and consultation.

 

Details

Tesamorelin Description:
Tesamorelin (INN) (trade name Egrifta) is a synthetic form of growth-hormone-releasing hormone (GHRH) which is used in the treatment of HIV-associated lipodystrophy. It is produced and developed by Theratechnologies, Inc. of Canada. The drug is a synthetic peptide consisting of all 44 amino acids of human GHRH with the addition of a trans-3-hexenoic acid group.
Tesamorelin has been shown to reduce lipodystrophy in HIV-infected individuals. Lipodystrophy is a condition that causes changes in placement of body fat, including wasting and fat accumulation, and changes in metabolism.
Similar to Tesamorelin is Sermorelin, which may be taken with GHRP-6 is clinical trials, that also promotes production and possible fat loss. Individuals with lipodystrophy may develop excess fat most notably around the liver, stomach, and other abdominal organs (visceral body fat).